Evaluation of a Scaling Approach for the Bioequivalence of Highly Variable Drugs
Open Access
- 26 August 2008
- journal article
- Published by Springer Science and Business Media LLC in The AAPS Journal
- Vol. 10 (3), 450-454
- https://doi.org/10.1208/s12248-008-9053-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Bioequivalence Approaches for Highly Variable Drugs and Drug ProductsPharmaceutical Research, 2007
- The bioequivalence of highly variable drugs and drug productsInternational journal of clinical pharmacology and therapeutics, 2005
- Novel Scaled Average Bioequivalence Limits Based on GMR and Variability ConsiderationsPharmaceutical Research, 2004
- Scaling or wider bioequivalence limits for highly variable drugs and for the special case of CmaxInternational journal of clinical pharmacology and therapeutics, 2003
- Limits for the scaled average bioequivalence of highly variable drugs and drug products.Pharmaceutical Research, 2003
- Non-traditional study designs to demonstrate average bioequivalence for highly variable drug products.European Journal of Clinical Pharmacology, 2001
- An Approach for Widening the Bioequivalence Acceptance Limits in the Case of Highly Variable DrugsPharmaceutical Research, 1995
- On population and individual bioequivalenceStatistics in Medicine, 1993
- Bioequivalence revisitedStatistics in Medicine, 1992
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987